Trimethoprim/Sulfamethoxazole Resistance in Urinary Tract Infections

Journal of Emergency Medicine

Volumn 36, Issue 4, 2009, Pages 338-341

  Guneysel, Ozlem ^a   Onur, Ozge ^a   Erdede, Mustafa ^a   Denizbasi, Arzu ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

bacterial resistance; fluoroquinolone; trimethoprim sulfamethoxazole; urinary tract infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFACLOR; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OUTPATIENT DEPARTMENT; PATHOGENIC ESCHERICHIA COLI; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINARY TRACT INFECTION; URINE CULTURE;

ADOLESCENT; ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; AZA COMPOUNDS; CEFTRIAXONE; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; QUINOLINES; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 64849100183     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.08.068     Document Type: Article

References (17)

1. Talan D.A., Naber K.G., Palou J., and Elkharrat D. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Int J Antimicrob Agents 23 Suppl 1 (2004) S54-S66
2. Nicolle L.E. Urinary tract infection: traditional pharmacologic therapies. Am J Med 113 Suppl 1A (2002) 35S-44S
3. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29 (1999) 745-758
4. Stratton C. Fluoroquinolone antibiotics: properties of the class and individual agents. Clin Ther 14 (1992) 348-375
5. Appelbaum P.C., and Hunter P.A. The fluoroquinolone antibacterials: past, present and future perspective. Int J Antimicrob Agents 16 (2000) 5-15
6. Naber K.G., Bergman B., Bishop M.C., et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40 (2001) 576-588
7. Goettsch W., van Pelt W., Nagelkerke N., et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands. J Antimicrob Chemother 46 (2000) 223-228
8. Hooton T.M. Practice guidelines for urinary tract infection in the era of managed care. Int J Antimicrob Agents 11 (1999) 241-245
9. Hooton T.M., and Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11 (1997) 551-581
10. Canbaz S., Peksen Y., Sunter A.T., Leblebicioglu H., and Sunbul M. Antibiotic prescribing and urinary tract infection. Int J Antimicrob Agents 20 (2002) 407-411
11. Karlowsky J.A., Kelly L.J., Thornsberry C., et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking resistance in the United States today. The surveillance network. Int J Antimicrob Agents 19 (2002) 21-31
12. Olafsson M., Kristinsson K.G., and Sigurdsson J.A. Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs-an observational study of uncomplicated urinary tract infections in Icelandic women. Scand J Prim Health Care 18 (2000) 35-38
13. Musa-Aisien A.S., Ibadin O.M., and Ukoh G. Prevalence and antimicrobial sensitivity pattern in urinary tract infection in febrile under-5s at a children's emergency unit in Nigeria. Ann Trop Pediatr 23 (2003) 39-45
14. Forrell D.J., Morrissey I., Rubeis D., Robbins M., and Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 46 (2003) 94-100
15. Turnidge J., Bell J., Biedenbach D.J., and Jones R.N. Pathogen occurence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY antimicrobial surveillance program 1998-1999. Int J Antimicrob Agents 20 (2002) 10-17
16. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOSENS Project. J Antimicrob Chemother 51 (2003) 69-76
17. Talan D.A., Stamm W.E., Hooton T.M., et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women. JAMA 283 (2000) 1583-1590